Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 30, 2020 07:00 ET | Source: Marinus Pharmaceuticals

Marinus Pharmaceuticals Provides Pipeline Update

Status Epilepticus pivotal Phase 3 trial on-track to begin in Q3 2020CDKL5 Deficiency Disorder Phase 3 trial results in Q3 2020 First patient enrolled in Phase 2 Tuberous Sclerosis Complex trial...
June 24, 2020 08:00 ET | Source: Marinus Pharmaceuticals

Marinus Pharmaceuticals to Host Pipeline Update Webinar

RADNOR, Pa., June 24, 2020 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure...
June 22, 2020 10:16 ET | Source: Marinus Pharmaceuticals

Marinus Pharmaceuticals to Present at SVB Leerink’s CybeRx Series: 2nd Annual CNS Forum

RADNOR, Pa., June 22, 2020 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure...
June 16, 2020 18:39 ET | Source: Marinus Pharmaceuticals

Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

RADNOR, Pa., June 16, 2020 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS) (the “Company” or “Marinus”), a pharmaceutical company dedicated to the development of innovative...
June 15, 2020 07:30 ET | Source: Marinus Pharmaceuticals

Marinus Pharmaceuticals Appoints Martha Manning as Vice President, General Counsel and Secretary

RADNOR, Pa., June 15, 2020 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat orphan seizure...